Related Experiment Videos
Enhanced effectiveness of intraperitoneal antibiotics administered via liposomal carrier
C I Price1, J W Horton, C R Baxter
1Department of Surgery, University of Texas Southwestern Medical Center, Dallas 75235-9031.
Abstract:
The local application of antibiotics to treat intraperitoneal contamination has been used with variable results. Liposomes are not rapidly absorbed from the peritoneal cavity, offering a potential delivery system for intraperitoneal antibiotics. The effects of liposome-incorporated antibiotic administration in a fecal peritonitis model were compared with the effects of conventional intraperitoneal and intramuscular antibiotics. Rats were divided into four groups: untreated, intramuscular cefoxitin, intraperitoneal cefoxitin, and intraperitoneal liposome-incorporated cefoxitin. Quantitative blood cultures were drawn at 4 and 24 hours. Liposome delivery of cefoxitin significantly reduced mortality and bacteremia at 4 and 24 hours compared with control subjects and conventional antibiotic groups. Peritoneal abscess formation tended to decrease in the liposome antibiotic group (mean +/- SEM, 6.86 +/- 0.79) compared with the group receiving free intraperitoneal administration of antibiotics (10.33 +/- 1.63). We conclude that liposomal delivery significantly enhances the effectiveness of cefoxitin in this model of peritonitis.
Insights
Liposome-encapsulated antibiotics show improved treatment for peritonitis. This novel delivery method significantly reduced mortality and bacterial infection compared to traditional antibiotic administration in rats.
Area of Science:
- Pharmacology
- Drug Delivery Systems
- Infectious Diseases
Background:
- Intraperitoneal antibiotic administration for peritonitis yields variable outcomes.
- Liposomes offer sustained drug release in the peritoneal cavity, suggesting potential for enhanced antibiotic delivery.
Purpose of the Study:
- To evaluate the efficacy of liposome-incorporated cefoxitin compared to conventional antibiotic administration in a rat model of fecal peritonitis.
Main Methods:
- Rats with induced fecal peritonitis were assigned to four groups: untreated, intramuscular cefoxitin, intraperitoneal cefoxitin, and intraperitoneal liposome-incorporated cefoxitin.
- Quantitative blood cultures were performed at 4 and 24 hours post-treatment.
Main Results:
- Liposomal cefoxitin significantly decreased mortality and bacteremia at both 4 and 24 hours compared to control and conventional antibiotic groups.
- Peritoneal abscess formation was reduced in the liposome group (6.86 +/- 0.79) versus the free intraperitoneal antibiotic group (10.33 +/- 1.63).
Conclusions:
- Liposomal delivery of cefoxitin significantly enhances therapeutic effectiveness in a peritonitis model.
- This approach offers a promising strategy for treating intraperitoneal infections.